Workflow
首药控股(北京)股份有限公司2025年第一次临时股东大会决议公告

Meeting Overview - The first extraordinary general meeting of shareholders for 2025 was convened by the board of directors and chaired by Chairman Li Wenjun, utilizing a combination of on-site and online voting methods [2][4] - The meeting complied with the provisions of the Company Law of the People's Republic of China and relevant regulations [2][4] Attendance - All 7 current directors and 3 current supervisors attended the meeting in person [5] Resolutions Passed - The following resolutions were approved: 1. Appointment of the auditing firm for the 2025 financial statements and internal control [4] 2. Change of registered address, cancellation of the supervisory board, and amendments to the Articles of Association [4] 3. Amendments to the rules of procedure for shareholder meetings [6] 4. Amendments to the rules of procedure for board meetings [6] 5. Amendments to the management measures for related party transactions [6] 6. Amendments to the management measures for external investments [6] 7. Amendments to the management measures for external guarantees [6] 8. Amendments to the management measures for the use of raised funds [6] 9. Amendments to the implementation details of cumulative voting [6] 10. Amendments to the independent director work system [7] Voting Results - Resolution 2 was a special resolution requiring a two-thirds majority, which was achieved [7] - All other resolutions were ordinary resolutions passed by a simple majority [7] Legal Verification - The meeting was witnessed by Beijing Jingtian Gongcheng Law Firm, confirming that the meeting's procedures and voting results were in compliance with Chinese laws and regulations [7]